Poster presentations: Clinical 2021
21 posters
Quality of life and fear of disease progression in MS patients with PTSD
Young Investigator
Mariia Andreeva
41
Sodium/potassium ratio as a conversion predictor from CIS to MS
Young Investigator
Marlene Arbeu-Reyes
11
Effect of Teriflunomide on Neurofilament Light Chain Levels in Children with RMS
Brenda Banwell
51
Ph1 OLE and imaging data for ATA188, an allogeneic EBV-targeted MS immunotherapy
Amit Bar-Or
30
Peripheral neuropathy as potential side effect of teriflunomide
Young Investigator
Serena Borrelli
5
Real world experience with Ocrelizumab in patients with PPMS: German NTD Registry
Stefan Braune
69
Patient-Reported Outcomes & their Interconnectivity in Multiple Sclerosis
Giampaolo Brichetto
24
Humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and controls
Young Investigator
Gabriel Bsteh
32
Long-term disability outcomes in multiple sclerosis: a 25-year follow-up study
Young Investigator
Sena Destan Bunul
77
NICARA: Clinically feasible detection of structural connectivity changes in MS
Markus Butz-Ostendorf
52
Frequency of New Silent MRI lesions in MOGAD and AQP4-NMOSD
Young Investigator
Valentina Camera
49
CONFIDENCE: Real-world effectiveness of ocrelizumab in relapsing MS over 18 months
Young Investigator
Julius Eggebrecht
25
Prevalence of PTSD in Russian population of MS patients
Young Investigator
Ivan Kalinin
40
Factors affecting cognitive impairment in Japanese patients with multiple sclerosis
Masaaki Niino
7
Quantify upper limb impairment in the ADL in people with Multiple Sclerosis
Young Investigator
Marco Pisa
14
Exercise therapy as supplemental treatment in early multiple sclerosis: a RCT
Winner Young Investigator Award
Young Investigator
Morten Riemenschneider
28
Konectomâ„¢ cognitive processing speed testing and the influence of reaction time
Matt Scaramozza
35
DigiToms Study: preliminary findings on Konectomâ„¢ digital outcome assessments in MS
Matt Scaramozza
50
Establishment of a ddPCR method for detecting Epstein-Barr Virus in MS samples
Tassja Spindler
59
The impact of COVID-19 on patients with neuromyelitis optica beyond infection risk
Young Investigator
Hexiang Yin
65
The epidemiology of COVID-19 and MS characteristics in a national sample in China
Yao Zhang
67